PT-141 (Bremelanotide) is a high-purity (≥99%) cyclic melanocortin receptor agonist with a molecular weight of 1025.2 Da. The sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH activates MC3R and MC4R for neuroendocrine research. Supplied as a lyophilized powder, store at -20°C protected from light. Used in melanocortin pathway and central nervous system studies.

Research Overview

PT-141 (Bremelanotide) is a synthetic peptide compound used in laboratory research settings. Researchers studying melanocortin receptor system research use this compound to investigate cellular signaling pathways, receptor binding affinities, and structure-activity relationships. Each batch is manufactured under controlled conditions and verified through HPLC and mass spectrometry analysis to ensure consistency across experimental replicates.